Expression of Angiogenesis-Related Genes Regulates Different Steps in the Process of Tumor Growth and Metastasis in Human Urothelial Cell Carcinoma of the Urinary Bladder

被引:43
作者
Chikazawa, M. [1 ]
Inoue, K. [1 ]
Fukata, S. [1 ]
Karashima, T. [1 ]
Shuin, T. [1 ]
机构
[1] Kochi Med Sch, Dept Urol, Nanko Ku, Kochi 7838505, Japan
关键词
Angiogenesis; Metastasis; Transitional cell carcinoma; Tumor progression; Urothelial cell carcinoma;
D O I
10.1159/000164218
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: This study was designed to determine the relative activity of angiogenesis-related genes in the regulation of tumorigenicity and subsequent metastases of urothelial cell carcinomas (UC) of the urinary bladder. Methods: We selected the clones with the highest and lowest expression level of basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF)/vascular permeability factor or interleukin-8 (IL-8) in the highly tumorigenic and metastatic human UC cell line 253J B-V. Tumorigenicity and production of spontaneous lymph node metastases were evaluated 1, 2, 4, 8 and 12 weeks after orthotopic implantation of each specific expression clone into the urinary bladder of athymic nude mice. Moreover, the transitional changes in the expression of angiogenesis-related genes and neovascularization were determined in tumors and metastases. Results: At the early stage of tumor growth following orthotopic implantation, tumorigenicity and metastases were significantly increased in the clones with the highest expression of bFGF and IL-8, while they were significantly inhibited in the clones with the lowest expression of bFGF and IL-8 compared to parental 253J B-V. In the tumors, specific expression of angiogenesis-related genes and intratumor neovascularity of each clone were gradually regulated to the same level as parental 253J B-V. In metastasized tumors of the highest and lowest IL-8-expressing clones, IL-8 expression was consistently high and low, respectively. Conclusions: These findings indicate that at the early stage of tumor growth, bFGF and IL-8 expression play important roles in the regulation of angiogenesis, tumorigenicity and subsequent metastases of human bladder cancer. Copyright (C) 2008 S. Karger AG, Basel
引用
收藏
页码:335 / 345
页数:11
相关论文
共 25 条
[1]   EXPRESSION OF BASIC FIBROBLAST GROWTH-FACTOR AND ITS RECEPTOR IN AN INVASIVE BLADDER-CARCINOMA CELL-LINE [J].
ALLEN, LE ;
MAHER, PA .
JOURNAL OF CELLULAR PHYSIOLOGY, 1993, 155 (02) :368-375
[2]   VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) GENE IS EXPRESSED DIFFERENTIALLY IN NORMAL-TISSUES, MACROPHAGES, AND TUMORS [J].
BERSE, B ;
BROWN, LF ;
VANDEWATER, L ;
DVORAK, HF ;
SENGER, DR .
MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (02) :211-220
[3]  
BROWN LF, 1993, AM J PATHOL, V143, P1255
[4]   A RAPID COLORIMETRIC INSITU MESSENGER-RNA HYBRIDIZATION TECHNIQUE USING HYPERBIOTINYLATED OLIGONUCLEOTIDE PROBES FOR ANALYSIS OF MDR1 IN MOUSE COLON-CARCINOMA CELLS [J].
BUCANA, CD ;
RADINSKY, R ;
DONG, ZY ;
SANCHEZ, R ;
BRIGATI, DJ ;
FIDLER, IJ .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1993, 41 (04) :499-506
[5]   QUANTIFICATION OF ANGIOGENESIS AS AN INDEPENDENT PREDICTOR OF PROGNOSIS IN INVASIVE BLADDER CARCINOMAS [J].
DICKINSON, AJ ;
FOX, SB ;
PERSAD, RA ;
HOLLYER, J ;
SIBLEY, GNA ;
HARRIS, AL .
BRITISH JOURNAL OF UROLOGY, 1994, 74 (06) :762-766
[6]   Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder [J].
Dinney, CPN ;
Babkowski, RC ;
Antelo, M ;
Perrotte, P ;
Liebert, M ;
Zhang, HZ ;
Palmer, J ;
Veltri, RW ;
Katz, RL ;
Grossman, HB .
JOURNAL OF UROLOGY, 1998, 160 (04) :1285-1290
[7]   ISOLATION AND CHARACTERIZATION OF METASTATIC VARIANTS FROM HUMAN TRANSITIONAL-CELL CARCINOMA PASSAGED BY ORTHOTOPIC IMPLANTATION IN ATHYMIC NUDE-MICE [J].
DINNEY, CPN ;
FISHBECK, R ;
SINGH, RK ;
EVE, B ;
PATHAK, S ;
BROWN, N ;
XIE, B ;
FAN, D ;
BUCANA, CD ;
FIDLER, IJ ;
KILLION, JJ .
JOURNAL OF UROLOGY, 1995, 154 (04) :1532-1538
[8]  
Inoue K, 2000, CANCER RES, V60, P2290
[9]  
Inoue K, 2002, CLIN CANCER RES, V8, P2389
[10]  
Inoue K, 2000, CLIN CANCER RES, V6, P4866